Comments submitted on: July 30, 2023
Comments submitted to: European Commission
Details: The MRCT Center submitted public comments on the proposed revision of the EU general pharmaceuticals legislation. In broad support of merging the Paediatrics Regulation with general pharmaceuticals legislation, our comments urged the European Commission to ensure pediatric medicines development remains an implementation priority to meet the needs of children throughout Europe.
Published on: June 19, 2023
Published in: Frontiers in Communication
Description: In their article entitled “Communicating complex numeric information in clinical research,” recently published in Frontiers in Communication, Dr. Barbara Bierer and Sylvia Baedorf Kassis present an overview of the numeric concepts that arise throughout the course of research participation, as well as important considerations when presenting such information.
Comments provided on: June 30, 2023
Comments provided to: ICER
Comments provided on: July 5, 2023
Comments provided to: NIH
Challenges in Decentralized Clinical Trials – Open Discussion Forum
The provisions of the Food and Drug Omnibus Reform Act of 2022 (“FDORA”) related to advancing diversity, equity, and inclusion in clinical trial enrollment and promoting clinical trial modernization
Proceedings from: Joint Task Force for Clinical Trial Competency Biannual Global Meeting on May 2, 2023
Held at: Virtual Meeting
Developed on: June 2023
Developed by: MRCT Center Pediatrics Workgroup and translated by the King Hussein Cancer Center
Developed on: June 2023
Developed by: MRCT Center Pediatrics Workgroup and translated by the King Hussein Cancer Center
Developed on: June 2023
Developed by: MRCT Center Pediatrics Workgroup and translated by the King Hussein Cancer Center
